CBA Annual Conference 2017  

The Chinese Biopharmaceutical Association (CBA-USA), one of the largest Chinese professional associations in the US, is going to collaborate with MedImmune/AstraZeneca to co-host its 22rd annual conference on June 25, 2017 at the beautiful campus and the state-of-art conference facility of MedImmune, a member of the AstraZeneca group, the largest biopharma company in the state of Maryland, in Gaithersburg, Maryland. 

The theme of the 22rd CBA annual conference is “Delivering Lifesaving Medicines to Patients through Innovation, Regulatory Reform and Global Partnership”. The theme has been carefully selected to address the critical importance of worldwide collaboration and partnership to capture the great opportunity for the advancement of innovative medicine and biopharmaceuticals in both USA and China. 

The conference provides a perfect venue for people from government, private agencies, biotech and pharmaceutical companies interested in policy issues, business development, and partnership in US and China. The conference will also include a number of distinguished speakers including:

• Dr. Craig Venter - Founder of Celera Genomics, The Institute for Genomic Research (TIGR) and the J. Craig Venter  Institute (JCVI)
• Dr. Robert Temple - Deputy Director of Clinical Science, FDA CDER
• Dr. Guoping Zhao - Executive Director of the Chinese National Human Genome Center at Shanghai 

Location: One MedImmune Way, Gaithersburg, MD 20878

Tickets (Sale Ends June 22nd):

• Non-Profit Organizations (FDA, NIH, & Others) - $30.00
• Industry (Including 1 Year Membership) - $70.00
• MEDI/AZ Employee - $30.00
• VIP (Lifetime Membership & VIP Reception Ticket) - $500

Purchase Tickets Online Today: https://www.eventbrite.com/e/2017-22nd-cba-annual-conference-tickets-34454639755